The Scottish Universities Life Sciences Alliance (SULSA) created the Assay Development Fund to bridge academia and industry in the drug discovery process, facilitating the production of high-quality assays.

This poster outlines the development of an efficient workflow that resulted in a robust portfolio of assays. Ultimately, this approach enabled the delivery of validated hit molecules for multiple projects while achieving a significant return on investment.